These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14221786)

  • 21. POTENTIATION OF THE ANTI-LEUKEMIC EFFECTS OF 2-AMINOTHIADIAZOLE BY ISONICOTINAMIDE AND DERIVATIVES.
    OETTGEN HF; PURPLE JR; COLEY VC; KRAKOFF IH; BURCHENAL JH
    Cancer Res; 1964 May; 24():689-92. PubMed ID: 14188475
    [No Abstract]   [Full Text] [Related]  

  • 22. STREPTOZOTOCIN.
    WHITE FR
    Cancer Chemother Rep; 1963 Jul; 30():49-53. PubMed ID: 14051504
    [No Abstract]   [Full Text] [Related]  

  • 23. ATTACK ON NUCLEOPROTEIN IN CLINICAL CANCER CHEMOTHERAPY.
    KNOCK FE
    J Am Geriatr Soc; 1965 Apr; 13():313-24. PubMed ID: 14279100
    [No Abstract]   [Full Text] [Related]  

  • 24. OSSAMYCIN, A NEW CYTOTOXIC AGENT.
    SCHMITZ H; JUBINSKI SD; HOOPER IR; CROOK KE; PRICE KE; LEIN J
    J Antibiot (Tokyo); 1965 Mar; 18():82-8. PubMed ID: 14326088
    [No Abstract]   [Full Text] [Related]  

  • 25. THE EFFECT OF A PHTHALANILIDE DERIVATIVE ON LIPIDE METABOLISM IN L1210 LEUKEMIA CELLS.
    GELLHORN A; WAGNER M; RECHLER M; KOREN Z; BENJAMIN W
    Cancer Res; 1964 Apr; 24():400-8. PubMed ID: 14147813
    [No Abstract]   [Full Text] [Related]  

  • 26. THE EFFECT OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE HYDROCHLORIDE ON MURINE NEOPLASMS.
    EVANS JS; MUSSER EA; BOSTWICK L; MENGEL GD
    Cancer Res; 1964 Aug; 24():1285-93. PubMed ID: 14216163
    [No Abstract]   [Full Text] [Related]  

  • 27. BIOCHEMISTRY OF CANCER (METABOLIC ASPECTS).
    BROCKMAN RW; ANDERSON EP
    Annu Rev Biochem; 1963; 32():463-512. PubMed ID: 14144487
    [No Abstract]   [Full Text] [Related]  

  • 28. CHEMOTHERAPEUTIC ACTIVITY OF PHTHALANILIDE DERIVATIVES. AN APPROACH TO ANTICODIC THERAPY?
    KENSLER CJ
    Cancer Res; 1963 Sep; 23():1353-63. PubMed ID: 14070389
    [No Abstract]   [Full Text] [Related]  

  • 29. COMBINED SYSTEMIC CHEMOTHERAPY AND CENTRAL NERVOUS SYSTEM IRRADIATION IN THE TREATMENT OF MICE WITH L1210 LEUKEMIA.
    JOHNSON RE
    Cancer Chemother Rep; 1963 Sep; 31():67-8. PubMed ID: 14066237
    [No Abstract]   [Full Text] [Related]  

  • 30. CELLULAR ACCUMULATION OF METHYLGLYOXAL-BIS-GUANYLHYDRAZONE IN VITRO. I. GENERAL CHARACTERISTICS OF CELLULAR UPTAKE.
    FIELD M; BLOCK JB; OLIVERIO VT; RALL DP
    Cancer Res; 1964 Dec; 24():1939-46. PubMed ID: 14247505
    [No Abstract]   [Full Text] [Related]  

  • 31. ACTION OF PLANT EXTRACTS ON TRANSPLANTED MOUSE TUMORS. SCREENING DATA. III.
    HARDINGE MG; COURVILLE DA; HARDINGE M; FUJIKAWA B; HARVEY R
    Cancer Res; 1964 Jan; 24():1-39. PubMed ID: 14106544
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. II.
    GOLDIN A; VENDITTI JM; KLINE I; MANTEL N
    Cancer Res; 1960 Jun; 20(5)Pt 2():382-469. PubMed ID: 13850662
    [No Abstract]   [Full Text] [Related]  

  • 33. [Current progress in cancer chemotherapy for childhood cancer].
    Fujimoto T
    Gan To Kagaku Ryoho; 1992 May; 19(5):579-87. PubMed ID: 1580631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the activity of cytoxan against leukemia L1210 in mice.
    VENDITTI JM; HUMPHREYS SR; GOLDIN A
    Cancer Res; 1959 Oct; 19():986-95. PubMed ID: 13841661
    [No Abstract]   [Full Text] [Related]  

  • 35. The differential effect of 8-azaguanine on nucleic acid and protein biosynthesis of leukemia L1210.
    BURDGE DC; MANDEL HG
    Cancer Chemother Rep; 1962 May; 18():1-4. PubMed ID: 13874751
    [No Abstract]   [Full Text] [Related]  

  • 36. EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.
    SKIPPER HE; SCHABEL FM; WILCOX WS
    Cancer Chemother Rep; 1964 Feb; 35():1-111. PubMed ID: 14117037
    [No Abstract]   [Full Text] [Related]  

  • 37. The influence of treatment schedule on the chemotheapy of advanced leukemia L1210 in mice.
    VENDITTI JM; GOLDIN A; KLINE I
    Cancer Chemother Rep; 1960 Feb; 6():55-7. PubMed ID: 13841660
    [No Abstract]   [Full Text] [Related]  

  • 38. EVALUATION OF ANTILEUKEMIC AGENTS IN THE TREATMENT OF DRUG RESISTANT VARIANTS OF LEUKEMIA L1210.
    VENDITTI JM; GOLDIN A
    Cancer Res; 1963 Jul; 23():SUPPL1011-84. PubMed ID: 14051510
    [No Abstract]   [Full Text] [Related]  

  • 39. [STUDIES IN REGARD TO THE POSSIBLE ANTI-NEOPLASTIC EFFECT OF THALIDOMIDE].
    BACH A; BICHEL J; HEJGAARD JJ
    Folia Clin Int (Barc); 1963 Nov; 13():511-9. PubMed ID: 14157974
    [No Abstract]   [Full Text] [Related]  

  • 40. Involvement of mitochondrial dynamics in the antineoplastic activity of cisplatin in murine leukemia L1210 cells.
    Han XJ; Shi SL; Wei YF; Jiang LP; Guo MY; Wu HL; Wan YY
    Oncol Rep; 2017 Aug; 38(2):985-992. PubMed ID: 28677814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.